BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jun 14, 2010
 |  BC Week In Review  |  Company News  |  Deals

Zealand Pharma, sanofi-aventis deal

Zealand and sanofi-aventis added a lixisenatide/ Lantus insulin glargine combination to their 2003 deal to develop and commercialize lixisenatide to treat Type II diabetes. Lixisenatide,...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >